DS
GYRE icon

DRW Securities’s Gyre Therapeutics GYRE Stock Holding History

DRW Securities’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,733
Closed -$152K – 74
2018
Q2 		$152K Buy
+1,733
New +$304K 0.01% 79
2018
Q1 		– Sell
-1,600
Closed -$164K – 304
2017
Q4 		$164K Buy
+1,600
New +$81.6K 0.02% 424
2015
Q1 		– Sell
-165
Closed -$342K – 122
2014
Q4 		$342K Buy
+165
New +$318K 0.04% 84

Other funds holding GYRE

NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

DRW Securities's GYRE Position: Q3 2018 in Review

DRW Securities sold out of Gyre Therapeutics (GYRE) in Q3 2018, closing a stake of 1,733 shares — an estimated $152K sold.

DRW Securities first reported a position in GYRE in Q4 2014 and held it in 3 quarters. The position peaked at $342K in Q4 2014. 70 funds tracked by Wall St. Rank hold GYRE as of Q3 2018.

  • DRW Securities reported no remaining Gyre Therapeutics position as of Q3 2018 after selling out during the quarter.
  • DRW Securities sold 1,733 Gyre Therapeutics shares in Q3 2018, an estimated $152K.
  • DRW Securities first reported a position in Gyre Therapeutics in Q4 2014 and held it in 3 quarters.
  • DRW Securities's Gyre Therapeutics position peaked at $342K in Q4 2014.
  • 70 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2018.

Based on DRW Securities's 13F filing for Q3 2018, filed 14 Nov 2018.